Non-ischemic Painful Intermittent Left Bundle Branch Block With Infra-Hisian Block Treated Successfully With

Rana Al-Zakhari1, Safa Aljammali1, Nicholas Sheets1

  • 1Internal Medicine, Richmond University Medical Center, New York, USA.

Cureus
|February 11, 2022
PubMed

Insights

Non-ischemic painful left bundle branch block (LBBB) causes chest pain due to ventricular dyssynchrony. Treatment with a biventricular pacemaker successfully resolved symptoms in a patient with intermittent LBBB.

Area of Science:

  • Cardiology
  • Electrophysiology
  • Clinical Case Reports

Background:

  • Non-ischemic painful left bundle branch block (LBBB) is a rare condition characterized by chest pain coinciding with LBBB appearance and resolution.
  • The exact mechanism remains unclear, though ventricular dyssynchrony is a proposed cause.

Observation:

  • A 65-year-old male presented with non-ischemic chest pain and intermittent left bundle branch block (ILBBB) with infra-Hisian conduction delay.
  • Coronary artery disease was ruled out via angiography.
  • An electrophysiology study was performed to investigate the cause of chest pain and guide management.

Findings:

  • The patient's ILBBB and associated chest pain were successfully managed with a biventricular pacemaker.
  • Electrophysiology studies are crucial for diagnosing painful LBBB in the absence of coronary artery disease.

Implications:

  • This case underscores the diagnostic value of electrophysiology studies in unexplained painful LBBB.
  • Biventricular pacing may be an effective treatment for symptomatic LBBB related to ventricular dyssynchrony.
  • Further research into the pathophysiology of non-ischemic painful LBBB is warranted.

Related Concept Videos

Mitral Stenosis III: Medical Management01:26

Mitral Stenosis III: Medical Management

Mitral stenosis, a condition marked by the narrowing of the mitral valve, necessitates an integrated approach for effective management. This approach includes preventative measures, medical therapy, and surgical interventions to reduce symptoms and prevent complications.PreventionPrevention of mitral stenosis primarily focuses on reducing the incidence of bacterial infections, particularly streptococcal infections, which can lead to rheumatic fever and subsequent valvular damage. Timely...
Dysrhythmias IV: Characteristics of Bradyarrhythmias01:18

Dysrhythmias IV: Characteristics of Bradyarrhythmias

Bradyarrhythmias are cardiac rhythm disorders characterized by a slower-than-normal heart rate, typically defined as fewer than 60 beats per minute. Some of which are discussed here:Sinus BradycardiaSinus bradycardia presents a heart rate lower than 60 beats per minute, with a regular rhythm originating from the SA node. The ECG typically shows normal P waves preceding each QRS complex, a normal PR interval (0.12 to 0.20 seconds), and a normal QRS duration (0.06 to 0.10 seconds).First-Degree AV...
Dysrhythmias VI: Management of Dysrhythmias01:25

Dysrhythmias VI: Management of Dysrhythmias

Dysrhythmia management involves a multifaceted approach, incorporating pharmacological treatments, medical procedures, surgical interventions, lifestyle modifications, and patient education.Pharmacological ManagementAntiarrhythmic Drugs:Class I (Sodium Channel Blockers): This class includes quinidine and procainamide, which reduce the speed of impulse conduction in the heart, stabilize the cardiac membrane, and control arrhythmias. Quinidine and procainamide are Class IA agents that prolong the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy V: Interprofessional Care01:29

Cardiomyopathy V: Interprofessional Care

Managing cardiomyopathy involves addressing underlying or precipitating causes, treating heart failure with medications, and implementing dietary changes and a balanced exercise and rest regimen.Lifestyle ModificationsCardiomyopathy patients should adopt a low-sodium diet to reduce fluid retention and manage heart failure. A personalized exercise and rest plan helps maintain physical fitness without overstraining the heart. Avoiding alcohol and tobacco is essential to prevent further damage to...